Edwards Lifesciences Corp’s recently made public that its CVP, JAPAC Lippis Daniel J. unloaded Company’s shares for reported $21183.0 on Apr 08 ’25. In the deal valued at $70.61 per share,300 shares were sold. As a result of this transaction, Lippis Daniel J. now holds 22,863 shares worth roughly $1.53 million.
Then, Lippis Daniel J. bought 300 shares, generating $21,183 in total proceeds.
Before that, Ullem Scott B. sold 11,250 shares. Edwards Lifesciences Corp shares valued at $797,267 were divested by the CVP, Chief Financial Officer at a price of $70.87 per share. As a result of the transaction, Ullem Scott B. now holds 30,387 shares, worth roughly $2.04 million.
Stifel upgraded its Edwards Lifesciences Corp [EW] rating to a Buy from a a Hold in a research note published on January 30, 2025; the price target was increased to $90 from $75. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who decreased its forecast for the stock in mid January from “a Peer perform” to “an Underperform”. BofA Securities also remained covering EW and has increased its forecast on December 16, 2024 with a “Buy” recommendation from previously “Neutral” rating.
Price Performance Review of EW
On Tuesday, Edwards Lifesciences Corp [NYSE:EW] saw its stock fall -2.80% to $67.07. Over the last five days, the stock has lost -6.68%. Edwards Lifesciences Corp shares have fallen nearly -9.40% since the year began. Nevertheless, the stocks have fallen -27.65% over the past one year. While a 52-week high of $95.25 was reached on 02/14/25, a 52-week low of $58.93 was recorded on 04/08/25. SMA at 50 days reached $71.55, while 200 days put it at $71.98.
Levels Of Support And Resistance For EW Stock
The 24-hour chart illustrates a support level at 65.40, which if violated will result in even more drops to 63.73. On the upside, there is a resistance level at 69.76. A further resistance level may holdings at 72.45. The Relative Strength Index (RSI) on the 14-day chart is 34.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 90.51%. Stochastics %K at 18.33% indicates the stock is a buying.
How much short interest is there in Edwards Lifesciences Corp?
A steep rise in short interest was recorded in Edwards Lifesciences Corp stocks on 2025-03-14, dropping by -2.45 million shares to a total of 9.45 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 11.9 million shares. There was a decline of -25.88%, which implies that there is a negative sentiment for the stock.
